By SITC Staff
The Society for Immunotherapy of Cancer’s (SITC) Certificate in Cancer Immunotherapy program is designed to offer physicians and health care providers the knowledge and skills to deliver effective care to cancer patients being treated with immunotherapy. As the field of immunotherapy evolves, SITC’s Certificate in Cancer Immunotherapy ensures that professionals will stay at the forefront of cancer care.
Learners will establish a comprehensive understanding of cancer immunotherapies, from checkpoint inhibitors to cutting-edge cell therapies and more. Participants can explore a diverse landscape of immunotherapeutic approaches and be equipped with a nuanced perspective, allowing them to tailor decisions to the unique needs of patients.
SITC’s Certificate in Cancer Immunotherapy program allows professionals to manage treatment-related complications and effectively address the potential side effects associated with cancer immunotherapy to improve patient outcomes. With a carefully crafted curriculum, learners will also be able to engage with the latest research, case studies and practice insights and directly apply it to everyday clinical scenarios.
Acquire an understanding of immunotherapies, practical implementation and drive the future of cancer care with SITC’s Certificate in Cancer program. The eight independent learning modules include:
Learn more about the Certificate in Cancer Immunotherapy program.
Certificate Program Task Force:
Chair, Robert L. Ferris, MD, PhD – UPMC Hillman Cancer Center
Umar Farooq, MD – University of Iowa
Silvia Formenti, MD – Weill Cornell Medicine
Sigrun Hallmeyer, MD – Advocate Medical Group
Jose Lutzsky, MD, FACP – University of Miami Sylvester Cancer Center
George Weiner, MD – University of Iowa
The information provided here is for your convenience only. ASTRO does not make any claims about the suitability or quality of the programs discussed.